The effects of chronic administration of ethosuximide on learning and memory: A behavioral and biochemical study on nonepileptic rats

Behavioural Pharmacology

Volumn 17, Issue 7, 2006, Pages 573-579

  Ponnusamy, Ravikumar ^a,b   Pradhan, Nithyananda ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ethosuximide; Frontal cortex; Hippocampus; Memory; Neurotransmitters; Passive avoidance; Rat; Spatial learning

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DOPAMINE; ETHOSUXIMIDE; GABAPENTIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLYCINE; PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN; SEROTONIN; TAURINE; VALPROIC ACID;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE; ARTICLE; CHRONIC DRUG ADMINISTRATION; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROCHEMICAL ANALYSIS; EPILEPSY; FEAR; FRONTAL CORTEX; GABAERGIC SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MEMORY DISORDER; NONHUMAN; PASSIVE AVOIDANCE; RAT;

ANIMALS; ANTICONVULSANTS; APPETITE; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; ETHOSUXIMIDE; FEAR; HIPPOCAMPUS; LEARNING; MALE; MAZE LEARNING; MEMORY; MOTIVATION; NEUROTRANSMITTER AGENTS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SPACE PERCEPTION;

EID: 33749506007     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fbp.0000236268.79923.18     Document Type: Article

References (32)

1. Acosta GB, Boccia MM, Baratti CM (2000). Gabapentin, an antiepileptic drug, improves memory storage in mice. Neurosci Lett 279:173-176.
2. Anagnostaras SG, Maren S, Sage JR, Goodrich S, Fanselow MS (1999). Scopolamine and Pavlovian fear conditioning in rats: dose-effect analysis. Neuropsychopharmacology 21:731-744.
3. Bolanos AR, Sarkisian M, Yang Y, Hori A, Helmers SL, Mikati M, et al. (1998). Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology 51:41-48.
4. Brioni JDHF, McGough JL (1997). Drug effects on learning and memory. In: Gerhard H, Vogel WHV, editors. Drug discovery and evaluation: pharmacological assays. 1st ed. Berlin, New York: Springer Verlag.
5. Chen C, Kim JJ, Thompson RF, Tonegawa S (1996). Hippocampal lesions impair contextual fear conditioning in two strains of mice. Behav Neurosci 110:1177-1180.
6. Clincke G, Wauquier A (1979). Metrazol-produced impairment of passive avoidance retention specifically antagonized by anti-petit mal drugs. Psychopharmacology (Berlin) 66:243-246.
7. Coulter DA, Huguenard JR, Prince DA (1989). Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol 25:582-593.
8. Decker MW, McGaugh JL (1991). The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7:151-168.
9. Glowinski J, Iversen LL (1966). Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 13:655-669.
10. Goldlust A, Su TZ, Welty DF, Taylor CP, Oxender DL (1995). Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res 22:1-11.
11. Holmes GL (1991). Do seizures cause brain damage? Epilepsia 32 (Suppl 5):S14-S28.
12. Holmes GL (1997). Epilepsy in the developing brain: lessons from the laboratory and clinic. Epilepsia 38:12-30.
13. Huang YY, Kandel ER (1995). D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc Natl Acad Sci USA 92:2446-2450.
14. Izquierdo I, Medina JH (1995). Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol Learn Mem 63:19-32.
15. Kalueff A, Nutt DJ (1996). Role of GABA in memory and anxiety. Depress Anxiety 4:100-110.
16. Kuzniecky R, Ho S, Pan J, Martin R, Gilliam F, Faught E, Hetherington H (2002). Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 58:368-372.
17. Lin-Michell E, Chweh AY, Swinyard EA (1986). Effect of ethosuximide alone and in combination with gamma-aminobutyric acid receptor agonists on brain gamma-aminobutyric acid concentration, anticonvulsant activity and neurotoxicity in mice. J Pharmacol Exp Ther 237:486-489.
18. Loscher W (1998). New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342:1-13.
19. McNamara RK, Skelton RW (1993). The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res Brain Res Rev 18:33-49.
20. Mondadori C, Classen W (1984). The effects of various antiepileptic drugs on e-shock-induced amnesia in mice: dissociability of effects on convulsions and effects on memory. Acta Neurol Scand Suppl 99:125-129.
21. Motamedi GK, Meador KJ (2004). Antiepileptic drugs and memory. Epilepsy Behav 5:435-439.
22. Murai S, Saito H, Abe E, Masuda Y, Itoh T (1992). A rapid assay for neurotransmitter amino acids, aspartate, glutamate, glycine, taurine and gamma-aminobutyric acid in the brain by high-performance liquid chromatography with electrochemical detection. J Neural Transm Gen Sect 87:145-153.
23. Murphy BL, Arnsten AF, Goldman-Rakic PS, Roth RH (1996). Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA 93:1325-1329.
24. Patsalos PN, Lascelles PT (1981). Changes in regional brain levels of amino acid putative neurotransmitters after prolonged treatment with the anticonvulsant drugs diphenylhydantoin, phenobarbitone, sodium valproate, ethosuximide, and sulthiame in the rat. J Neurochem 36:688-695.
25. Picker M, White W, Poling A (1985). Effects of phenobarbital, clonazepam, valproic acid, ethosuximide, and phenytoin on the delayed matching-to-sample performance of pigeons. Psychopharmacology (Berlin) 86:494-498.
26. Pradhan N, Arunasmitha S, Udaya HB (1990). Behavioral and neurochemical differences in an inbred strain of rats. Physiol Behav 47:705-708.
27. Quartermain D, Judge ME (1983). Recovery of memory following forgetting induced by depletion of biogenic amines. Pharmacol Biochem Behav 18:179-184.
28. Scuvee-Moreau J, Lepot M, Brotchi J, Gerebtzoff MA, Dresse A (1977). Action of phenytoin, ethosuximide and of the carbidopa-L-dopa association in semi-chronic cobalt-induced epilepsy in the rat. Arch Int Pharmacodyn Ther 230:92-99.
29. Sudha S, Lakshmana MK, Pradhan N (1995a). Changes in learning and memory, acetylcholinesterase activity and monoamines in brain after chronic carbamazepine administration in rats. Epilepsia 36:416-422.
30. Sudha S, Lakshmana MK, Pradhan N (1995b). Chronic phenytoin induced impairment of learning and memory with associated changes in brain acetylcholine esterase activity and monoamine levels. Pharmacol Biochem Behav 52:119-124.
31. Sudha S, Lakshmana MK, Pradhan N (1996). Phenobarbital in the anticonvulsant dose range does not impair learning and memory or alter brain AChE activity or monoamine levels. Pharmacol Biochem Behav 54:633-638.
32. Trimble MR, Thompson PJ (1981). Memory, anticonvulsant drugs and seizures. Acta Neurol Scand Suppl 89:31-41.